Biologics manufacturing stands at an exciting crossroads, with soaring demand for therapies juxtaposed against the persistent need to streamline operations and reduce costs. In the realm of upstream processes, the quest is to enhance productivity with limited resources and in shorter timeframes. A promising avenue that has emerged to address this challenge is intensified fed-batch processing, a method that combines perfusion-enabled seeding with refined feeding strategies. This innovative approach has the potential to boost productivity significantly, cut production costs, and minimize facility sizes, offering a beacon of hope for biologics developers.
Yuxin Liu, PhD, a senior scientist specializing in culture development at Sanofi, unveiled the transformative impact of intensified fed-batch processing during her presentation at the Bioprocessing International Conference in Boston. By leveraging high-density seeding and transitioning from daily adjustments based on viable cell density (VCD) to a fixed-volume feeding regimen, Liu and her team achieved a remarkable surge in titers—from 7 g/L to 18 g/L within a mere 14 days. The adoption of a fixed-volume approach not only ramped up yields but also simplified operational procedures. With a predetermined quantity of feed from the outset, the necessity for daily cell counts was eliminated, consequently reducing variability across runs.
Championing the cause of intensified fed-batch processing, Liu highlighted several key advantages:
- Enhanced productivity: The transition to high-density cultures necessitates meticulous attention to media, ensuring the ideal balance of nutrients, solubility, and stability.
- Optimized formulations: To counter challenges such as lactate accumulation, amino acid depletion, and fluctuating harvest quality, new feed formulations were developed. These formulations boasted optimized amino acid profiles, supplemented nucleotides and antioxidants, and improved redox balance, enabling heightened productivity while upholding product quality.
- Streamlined operations: A pivotal aspect of this approach is its simplified feeding strategy, which eases the burden on manufacturing teams. By sidestepping the need for daily sampling and adjustments, this method not only saves time and labor but also enhances reproducibility at scale.
Nevertheless, the road to intensified fed-batch processing is not without obstacles. The transition to high-density cultures entails exacting demands on media formulations, necessitating precise nutrient compositions, solubility characteristics, and stability profiles. Initial trials uncovered challenges such as lactate accumulation, amino acid deficiencies, and inconsistent harvest quality. To navigate these hurdles, Liu’s team developed novel feed formulations featuring optimized amino acid distributions, fortified nucleotides and antioxidants, and enhanced redox equilibrium. These strategic enhancements not only bolstered productivity levels but also preserved the integrity of the final product.
Liu’s insights shed light on the transformative potential of intensified fed-batch processing, heralding a paradigm shift in upstream bioprocessing. By offering heightened efficiency, expedited development timelines, and a more robust route to market for biologics, this innovative approach holds the promise of reshaping the landscape of biologics manufacturing.
In conclusion, intensified fed-batch processing emerges as a beacon of hope for biologics developers grappling with the dual challenges of escalating demand and cost constraints. By amalgamating high-density seeding with streamlined feeding strategies, this revolutionary approach not only augments productivity and slashes production costs but also simplifies operational intricacies. As the biologics industry hurtles towards a future defined by efficiency, agility, and innovation, intensified fed-batch processing stands poised to catalyze a new era of progress and growth in biologics manufacturing.
Takeaways:
– Intensified fed-batch processing offers a transformative solution for biologics manufacturing, enhancing productivity and reducing costs.
– By optimizing feed formulations and adopting high-density seeding, intensified fed-batch processing streamlines operations and boosts reproducibility.
– The innovative approach heralds a paradigm shift in upstream bioprocessing, promising faster development timelines and a more efficient path to market for biologics.
Tags: upstream, biotech
Read more on genengnews.com